A Study of LY3314814 in Participants With Liver Impairment
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
PK Study of Ticagrelor in Children Aged Less Than 24 Months, With Sickle Cell Disease (HESTIA4)
- Status
- COMPLETED
- Phase
- PHASE1
Durvalumab and "Booster" Radiation in Metastatic Adenocarcinoma of the Pancreas
- Status
- TERMINATED
- Phase
- PHASE2
Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2)
- Status
- COMPLETED
- Phase
- PHASE2
A Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Osimertinib in Clinical Practice Among Chinese NSCLC Patients
- Status
- COMPLETED
- Phase
- N/A
Impact of Specialist Led Integrated Care in COPD
- Status
- UNKNOWN
- Phase
- NA
Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Benralizumab for Eosinophilic Gastritis (BEGS)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Durvalumab and Tremelimumab With Gemcitabine or Gemcitabine/Cisplatin Compared to Gemcitabine/Cisplatin in CCA Patients
- Status
- COMPLETED
- Phase
- PHASE2
Durvalumab (MEDI4736) and TREmelimumab in NEOadjuvant Bladder Cancer Patients (DUTRENEO)
- Status
- COMPLETED
- Phase
- PHASE2
Study to Assess Prevalence of BRCA1 and BRCA2 Mutation Among Ovarian, Primary Peritoneal and Fallopian Tube Cancer Patients in India
- Status
- COMPLETED
- Phase
- N/A
Olaparib After Response to Trabectedin-pegylated Liposomal Doxorubicin in Recurrent Ovarian Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Benralizumab in Patients With Inadequate Response to Anti-IL5 Monoclonal Antibody Therapies
- Status
- COMPLETED
- Phase
- PHASE3
Open-label PET Study With [11C]Osimertinib in Patients With EGFRm NSCLC and Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE1
Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
An Observational Study to Evaluate AZD9291 Treatment in Patients With T790M Positive Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
A Single Oral Dose Study to Evaluate Four Different Formulations of AZD9977 and the Effect of Food in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2